169 related articles for article (PubMed ID: 8691074)
41. Evidence for distinct intracellular pools of receptors for C3b and C3bi in human neutrophils.
O'Shea JJ; Brown EJ; Seligmann BE; Metcalf JA; Frank MM; Gallin JI
J Immunol; 1985 Apr; 134(4):2580-7. PubMed ID: 3156186
[TBL] [Abstract][Full Text] [Related]
42. Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3.
Myones BL; Dalzell JG; Hogg N; Ross GD
J Clin Invest; 1988 Aug; 82(2):640-51. PubMed ID: 2969921
[TBL] [Abstract][Full Text] [Related]
43. Contribution of CR3, CD11b/CD18 to cytolysis by human NK cells.
Klein E; Di Renzo L; Yefenof E
Mol Immunol; 1990 Dec; 27(12):1343-7. PubMed ID: 1980339
[TBL] [Abstract][Full Text] [Related]
44. Modulation of complement receptors of a human monocyte cell line, U-937, during incubation with phorbol myristate acetate: expression of an iC3b-specific receptor (CR3).
Gilbert D; Peulve P; Daveau M; Ripoche J; Fontaine M
Eur J Immunol; 1985 Oct; 15(10):986-91. PubMed ID: 2932340
[TBL] [Abstract][Full Text] [Related]
45. C1q acts synergistically with phorbol dibutyrate to activate CR1-mediated phagocytosis by human mononuclear phagocytes.
Bobak DA; Frank MM; Tenner AJ
Eur J Immunol; 1988 Dec; 18(12):2001-7. PubMed ID: 2975599
[TBL] [Abstract][Full Text] [Related]
46. Fibronectin-enhanced phagocytosis of an alternative pathway activator by human culture-derived macrophages is mediated by the C4b/C3b complement receptor (CR1).
Bohnsack JF; O'Shea JJ; Takahashi T; Brown EJ
J Immunol; 1985 Oct; 135(4):2680-6. PubMed ID: 3161946
[TBL] [Abstract][Full Text] [Related]
47. Complement receptor 3 (CD11b/CD18) mediates type I and type II phagocytosis during nonopsonic and opsonic phagocytosis, respectively.
Le Cabec V; Carréno S; Moisand A; Bordier C; Maridonneau-Parini I
J Immunol; 2002 Aug; 169(4):2003-9. PubMed ID: 12165526
[TBL] [Abstract][Full Text] [Related]
48. Characterization of patients with an increased susceptibility to bacterial infections and a genetic deficiency of leukocyte membrane complement receptor type 3 and the related membrane antigen LFA-1.
Ross GD; Thompson RA; Walport MJ; Springer TA; Watson JV; Ward RH; Lida J; Newman SL; Harrison RA; Lachmann PJ
Blood; 1985 Oct; 66(4):882-90. PubMed ID: 3899217
[TBL] [Abstract][Full Text] [Related]
49. Sodium fluoride reveals multiple pathways for regulation of surface expression of the C3b/C4b receptor (CR1) on human polymorphonuclear leukocytes.
Okada K; Brown EJ
J Immunol; 1988 Feb; 140(3):878-84. PubMed ID: 2963068
[TBL] [Abstract][Full Text] [Related]
50. Differential complement activation pathways promote C3b deposition on native and acetylated LDL thereby inducing lipoprotein binding to the complement receptor 1.
Klop B; van der Pol P; van Bruggen R; Wang Y; de Vries MA; van Santen S; O'Flynn J; van de Geijn GJ; Njo TL; Janssen HW; de Man P; Jukema JW; Rabelink TJ; Rensen PC; van Kooten C; Cabezas MC
J Biol Chem; 2014 Dec; 289(51):35421-30. PubMed ID: 25349208
[TBL] [Abstract][Full Text] [Related]
51. Binding and catabolism of aggregated immunoglobulins bearing C3b or iC3b by U937 cells.
Daha MR; Gorter A; Leijh PJ; Klar N; van Es LA
Immunology; 1988 Jul; 64(3):375-9. PubMed ID: 2970428
[TBL] [Abstract][Full Text] [Related]
52. Identification of an anti-monocyte monoclonal antibody that is specific for membrane complement receptor type one (CR1).
Hogg N; Ross GD; Jones DB; Slusarenko M; Walport MJ; Lachmann PJ
Eur J Immunol; 1984 Mar; 14(3):236-43. PubMed ID: 6368248
[TBL] [Abstract][Full Text] [Related]
53. Exposure to complement-bearing immune complexes enhances the in vitro sequestration of erythrocytes from young but not elderly donors.
Shapiro S; Pilar T; Gershon H
Clin Exp Immunol; 1993 Feb; 91(2):301-7. PubMed ID: 8428395
[TBL] [Abstract][Full Text] [Related]
54. Characterization of the human glomerular C3 receptor as the C3b/C4b complement type one (CR1) receptor.
Fischer E; Appay MD; Cook J; Kazatchkine MD
J Immunol; 1986 Feb; 136(4):1373-7. PubMed ID: 2418113
[TBL] [Abstract][Full Text] [Related]
55. Mechanism of transfer of immune complexes from red blood cell CR1 to monocytes.
Emlen W; Carl V; Burdick G
Clin Exp Immunol; 1992 Jul; 89(1):8-17. PubMed ID: 1385769
[TBL] [Abstract][Full Text] [Related]
56. Erythrocyte enhancement of C3b-mediated phagocytosis by human neutrophils in vitro: a combined effect of the erythrocyte complement receptors CR1 and erythrocyte scavengers to reactive oxygen metabolites (ROM).
Forslid J; Hed J; Stendahl O
Immunology; 1985 May; 55(1):97-103. PubMed ID: 3158597
[TBL] [Abstract][Full Text] [Related]
57. Cutting edge: productive HIV-1 infection of dendritic cells via complement receptor type 3 (CR3, CD11b/CD18).
Bajtay Z; Speth C; Erdei A; Dierich MP
J Immunol; 2004 Oct; 173(8):4775-8. PubMed ID: 15470016
[TBL] [Abstract][Full Text] [Related]
58. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3.
Schlesinger LS; Bellinger-Kawahara CG; Payne NR; Horwitz MA
J Immunol; 1990 Apr; 144(7):2771-80. PubMed ID: 2108212
[TBL] [Abstract][Full Text] [Related]
59. Processing of C3b-opsonized immune complexes bound to non-complement receptor 1 (CR1) sites on red cells: phagocytosis, transfer, and associations with CR1.
Craig ML; Waitumbi JN; Taylor RP
J Immunol; 2005 Mar; 174(5):3059-66. PubMed ID: 15728520
[TBL] [Abstract][Full Text] [Related]
60. Binding of C3b and C4b by the CR1-like site in murine CR1.
Kalli KR; Fearon DT
J Immunol; 1994 Mar; 152(6):2899-903. PubMed ID: 8144890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
